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Experimental Procedures
Materials
The R18/11 peptide, RDLSWLDLEAN, was synthesized by Dr. M. Berne (Tufts University), and HPLC-purified by Dr. J. Gorka (Biomolecules Midwest). Precast SDS-PAGE gels used for MS analysis were from Biorad, and the colloidal Coomassie protein stain was from Invitrogen.
Vivaspin and Centricon centrifugal concentrators were from Vivascience and Amersham, respectively. All other reagents were from Sigma or Fisher Scientific, and were reagent grade.
Antibodies, Western blotting and immunoprecipitation
Antibodies against 14-3-3 (K19), glutathione S-transferase (GST), Cdc25B, Cdc25C, PCTAIRE 2, PCTAIRE 3, TSC2 (tuberin), nucleolin (C23), nucleophosmin, Chk1, HDAC4 and Wee1 were purchased from Santa Cruz. Antibodies against human Cdc25A were from Neomarkers, and antibodies against EMK/Par1B have been described (32) . Cdc25C was detected with ascites generated from a monoclonal Cdc25C antibody (13) . C-TAK1 was detected with ascites generated using a monoclonal antibody produced with bacterially purified His-tagged human C-TAK1 (hPar-1a). For Western blotting, antibodies were dissolved in 5 % milk in TBST (50 mM Tris-HCl pH 8.0, 0.15 M NaCl, 0.02 % Tween-20), and membranes were washed 3 times in TBST after application of both primary and secondary antibody. Bound primary antibodies were detected with horseradish peroxidase-conjugated goat anti-mouse (Jackson), goat anti-rabbit (Zymed), or donkey anti-goat (Santa Cruz) secondary antibodies, and visualized using the ECL reagent (Amersham). Proteins were immunoprecipitated from 1 mg of total cell lysate, using 6 either anti-FLAG (M2) agarose (Sigma), anti-myc (9E10) agarose (Santa Cruz), or anti-TSC2 antibody bound to Protein A beads (Pierce).
14-3-3 Far Western analysis
For 14-3-3 Far Western analysis, samples were subjected to SDS-PAGE and transferred to nitrocellulose membranes as for a Western blot. Proteins bound to the membrane were denatured by incubating for at least 1 hour in denaturation buffer (50 mM Tris-HCl pH 8.0, 6 M guanidine-HCl, 6.25 mM EDTA, 1 mM DTT, 10 % glycerol, 0.05 % Tween-20), then renatured by incubating for at least 1 hour in renaturation buffer (denaturation buffer without guanidineHCl or DTT). Membranes were blocked for 1 hour in 5 % milk in TBST, rinsed in TBST, then incubated for 2 hours at room temperature or overnight at 4°C in TBST containing 0.1 mg/ml GST-14-3-3z and s, and 1 mg/ml bovine serum albumin. Where the R18/11 peptide was used to check binding specificity, the GST-14-3-3 protein mixture was pre-incubated with 0.1 mM peptide for 1 hour prior to use. Membranes were washed 3 times in TBST, then incubated for 1 hour with anti-GST primary antibody in 5 % milk / TBST. Bound primary antibody was detected with horseradish peroxidase-conjugated secondary antibody, and visualized using ECL reagent, as for Western blotting.
14-3-3 affinity chromatography
All purification steps were carried out at 4°C. Mitotic and interphase HeLa cells were lysed by incubation on ice for 15 min in a hypotonic lysis buffer (20 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM microcystin-LR, 1 mM DTT, plus Sigma protease inhibitor cocktail), followed by Dounce homogenization. The lysate (lysate 8 patterns shown are representative of 3 separate purifications, with MS/MS analysis carried out once.
After in-gel trypsinization, peptide sequences were determined by microcapillary reversed-phase chromatography coupled to a Finnigan LCQ DECA XP+ quadrupole ion trap mass spectrometer as in (33) . To improve data analysis, the resulting MS/MS spectra were preprocessed with inhouse custom software that recombined identical spectra (CombIon), determined precursor charge state without a high resolution scan (ZSA), and increased the accuracy of the precursor assignment (CorrectIon). Interpretation of the resulting MS/MS spectra of the peptides was facilitated by database correlation with the algorithm SEQUEST followed by manual examination of the MS/MS spectra. This large scale evaluation was aided by creating a working superset of peptide sequences with two programs written in-house. The first, ScoreFinal, uses a neural network to synthesize a single normalized score (S f 0.0-1.0) from the five SEQUEST scores (Sp, RSp, Ions, XCorr, DeltaCn) as well as peptide length, precursor charge state and database size. The second, SigCalc, independently calculates the probability (P) that MS/MS product ions observed would match the peptide's predicted fragment ions as a random event. The working set were those sequences that met the criteria S f . >= 0.5, P >= 10 -6 ; or the sum of S f >= 0.85 for two or more spectra identifying the same protein. From this set, final identifications were always confirmed by rigorous manual validation of the MS/MS spectra.
Expression of recombinant GST and GST-14-3-3, and preparation of GST-14-3-3 and control
GST affinity columns BL21 cells were transformed with plasmids encoding GST or GST-tagged 14-3-3z. Cultures were grown in a Bioflo 5000 fermenter (New Brunswick Scientific) at 37°C with TB medium 9 containing 0.2 % glucose, and under 30 % O 2 , to an A 600 of 0.6. Isopropyl-1-thio-ß-Dgalactopyranoside (IPTG) was added to a final concentration of 1 mM. After growing for an additional 4 h, cells were pelleted by continuous centrifugation. Cell pellets were resuspended in bacterial cell lysis buffer (50 mM Hepes-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA), containing 1.25% N-lauryl sarcosine supplemented with 1 mM DTT, 1 mg/ml lysozyme, and protease inhibitors (4 mM PMSF, 20 µg/ml aprotinin, 40 µM leupeptin, 1 mM benzamidine). After rocking at 4°C for 20 min, cells were lysed by sonication. Lysates were clarified by centrifugation (12,000 x g for 15 min), and Triton X-100 was added to a final concentration of 1%. Proteins were precipitated with glutathione-agarose beads and washed once with bacterial lysis buffer, twice with 10 volumes 50 mM Hepes-HCl pH 7.5 containing 0.5 M LiCl, and 3 times with 10 volumes 50 mM Hepes-HCl pH 7.5, 0.1 M NaCl, 1 mM EDTA, 1 mM DTT. GST fusion proteins were eluted with 20 mM glutathione in the same buffer, and protein-containing fractions were pooled and dialysed overnight against buffer without glutathione, plus 1 mM benzamidine and 4 mM PMSF. The levels of GST fusion proteins were estimated by comparison to a BSA standard after SDS-PAGE and Coomassie blue staining. Purified GST or GST-14-3-3 was covalently coupled to activated CH sepharose (Sigma) according to the manufacturer's instructions. 2.5 mg protein was bound per 1 ml swollen beads. GST and 14-3-3 columns were washed extensively and equilibrated in low salt buffer immediately before use.
GST-14-3-3 pull-down experiments
HeLa cells were lysed in 50 mM Tris-HCl pH 8.0, 0.1M NaCl, 5 mM EDTA, 0.5 % NP-40, 1 mM DTT, 1 mM microcystin-LR, plus protease inhibitors. Lysates were clarified by centrifugation at 16,000 x g. The lysate was pre-incubated with glutathione agarose without any 10 GST fusion proteins for 1 hour at 4 °C. Meanwhile, bacterial cell lysate expressing GST-14-3-3z was incubated with glutathione agarose for 1 h at 4 °C. The beads were washed with 0.5 M LiCl in 50 mM Tris-HCl pH 8.0, followed by HeLa cell lysis buffer, then incubated with 1 -2 mg precleared HeLa cell extract for 1 h at 4 °C. Beads were washed four times in HeLa cell lysis buffer, and bound proteins were eluted by boiling in SDS-PAGE sample buffer.
Cell culture and cell cycle synchronization
HeLa cells were routinely maintained in DMEM supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin and streptomycin. To prepare non-nocodazole-treated mitotic cells, asynchronously growing cells were treated with 2 mM thymidine for 16 h, then released from the block by switching to complete growth medium containing 24 µM each of thymidine and deoxycytidine. After 8 h, thymidine was added to the medium to a final concentration of 2 mM, and cells were cultured for an additional 16 h, to synchronize them at the G1-S border.
Cells were then rinsed twice with PBS and cultured in complete growth medium for a further 7 -10 hours, when mitotic cells were collected by shake-off. For interphase samples, asynchronously growing cells were harvested at 60 -90 % confluence. To obtain nocodazolesynchronised mitotic cells, 100 ng/ml nocodazole was added to the growth medium of asynchronously-growing cells, and cells were harvested by shake-off after 10 -12 hours. Cell cycle phase was determined by flow cytometry by using a Becton-Dickinson FACScan. Cells were stained with 30 µg/ml propidium iodide for DNA content, and for phospho-histone H3 content to identify mitotic cells as described (34) . FACS data were analyzed using CELLQUEST software. Transient transfection of HeLa cells was carried out using Fugene 6 (Roche), according to the manufacturer's instructions. be specific because 14-3-3 binding was specifically competed with an 11 amino acid peptide derived from the R18 peptide ( Fig. 1 , panel C). R18 is a hydrophobic peptide that binds to the amphipathic target-binding groove of the 14-3-3 dimer (35, 36) . Although it is not itself phosphorylated, R18 can displace phosphorylated target proteins from the 14-3-3 binding groove. Further evidence for specificity comes from the observation that 14-3-3 binding to target proteins was abolished by protein phosphatase treatment (see Fig. 2B, lanes 11,14) . These results demonstrated that there are cell cycle-specific differences in 14-3-3 binding partners that can be detected by Far Western analysis, and that nocodazole can be used to synchronize mitotic HeLa cells for large scale purification of 14-3-3 binding partners.
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Purification of 14-3-3-binding proteins from interphase and mitotic cells -Next, a purification scheme was developed to isolate sufficient quantities of 14-3-3 binding proteins for identification by mass spectrometry (Figure 2A ). For large-scale protein purification, HeLa cells were harvested from asynchronously growing cell cultures or from cells that had been synchronized in mitosis with nocodazole. FACS analysis of propidium iodide-and phospho-histone H3-stained cells (34) was used to confirm cell cycle phases: the asynchronous population used for purification contained 97% interphase cells, while the nocodazole-treated population contained at least 90% mitotic cells (data not shown). Cells were snap-frozen, and then thawed in lysis buffer for protein purification.
Proteins were precipitated from the cell lysate with 80% ammonium sulphate, resuspended in buffer, and passed over a GST column to remove GST-binding proteins.
Samples were then applied to either a GST control column, or a GST-14-3-3z column. The 14-3-3-binding activity passed through the GST control column ( Figure 2B , lanes 5, 6, 15, 16), but a large portion was retained on the GST-14-3-3z affinity column (Fig. 2B , lanes 3, 4, 9, 12). The presence of endogenous 14-3-3s in the HeLa cell lysate or dephosphorylation of target proteins may have prevented some 14-3-3-binding proteins binding to the 14-3-3 column (lanes 3, 4). The 14-3-3-binding proteins remained bound to the 14-3-3 column during the high salt wash (lanes 7, 8) and were eluted by the 14-3-3-binding R18/11 peptide (lanes 9, 12). In contrast, few proteins were eluted from the GST control column by the peptide (lanes 15, 16) . Binding of proteins to GST-14-3-3 was phosphorylation-dependent, because phosphatase treatment eliminated binding (lanes 11, 14) . Protein yields at various stages of the purification are shown in Figure 2A .
14 Proteins eluted from each of the columns were concentrated, subjected to SDS-PAGE, and visualized with colloidal Coomassie stain ( Figure 2C ). Differences were readily apparent between the mitotic (lane 1) and interphase (lane 2) column eluates. The eluted protein pools should contain proteins that bind to 14-3-3s directly, but may also include proteins that bind to the column due to their association with 14-3-3 binding proteins. Proteins were excised from the gel and pooled according to the apparent molecular mass and abundance of each band. The apparent molecular mass of many, though not all, of the excised bands corresponded to bands that were observed in 14-3-3 Far Westerns (not shown). Proteins were extracted from the gel, trypsinized, and peptides were identified by LC-MS/MS analysis.
Identification of interphase and mitotic 14-3-3-binding proteins -In total, 209 proteins were
identified in the mitotic 14-3-3-binding pool, and 184 from the interphase pool (Table 1, and   Supplementary Table 1 ). Of these, 89 were identified in both the interphase and mitotic samples. Table 1 if a function could be inferred from sequence homology with characterized proteins, from homology with functional protein domains, or from the circumstances under which EST sequences were isolated.
15
Several prominent 14-3-3-interacting proteins seen in Far Westerns (Figure 1, 2B ) and by colloidal Coomassie staining ( Figure 2C ) are dramatically different between interphase and mitotic samples. For instance, much more 14-3-3 binding activity was present at around 120 kDa in mitotic samples, and many more proteins of around that size were purified from mitotic samples. This region of the gel was excised and found to contain at least 18 different proteins; the relative abundance and contribution of each to 14-3-3 binding is not known at this time.
Confirmation of 14-3-3 interaction with identified proteins in interphase and mitosis -It is
important to note that although a given protein may have been identified under only one of the two experimental conditions tested (interphase or mitosis), it may in fact have bound to the 14-3-3 column equally well under both conditions, but only have been detected in one set of samples.
Thus, the interaction of 14-3-3 with a subset of identified target proteins was tested in GST-14-3-3 pull-down experiments (Figure 3) . These experiments were performed with interphase and mitotic lysates to confirm 14-3-3 associations and to explore differences between the ability of a given protein to bind to 14-3-3s during interphase and mitosis. As seen in Figure 3 , several known 14-3-3 targets bound to 14-3-3 in this assay, including the cell cycle regulator Wee1; the Par-1a (C-TAK1) and Par-1b (EMK) kinases which have been implicated in regulating cell polarity, microtubule dynamics, and the cell division cycle (32, 37, 38) ; Histone deacetylase 4, whose nucleo-cytoplasmic shuttling is regulated by 14-3-3 binding (39); and TSC2, a tumor suppressor protein that negatively regulates TOR (40-42). As expected, the known 14-3-3-binding proteins Cdc25A and Cdc25C, although not detected in our MS analysis, specifically bound to 14-3-3 in the pull-downs during interphase but not mitosis. Novel 14-3-3 binding partners identified here include the PCTAIRE 2 and 3 protein kinases, and a fragment of 16 C23/nucleolin, a nucleolar phosphoprotein of unknown function. In addition to these GST-14-3-3 pull-down experiments, 14-3-3 Far Westerns were carried out where possible, to determine whether 14-3-3 binding to the identified interacting proteins was direct (Figure 4) .
In some cases, interactions between 14-3-3s and identified target proteins could not be confirmed by GST-14-3-3 pull-down, 14-3-3 Far Western analysis or by co-immunoprecipitation experiments. This was the case for Hus 1, purified histones and nucleophosmin (Table 2 and data not shown). Nucleophosmin binds to the 14-3-3 binding protein nucleolin (43), and may have been isolated on the 14-3-3 column because of its association with nucleolin. Finally, many of the identified proteins could not be confirmed as 14-3-3 targets due to lack of available reagents.
The interaction of 14-3-3s with Cdc25 family members and with Wee1 showed the expected cell cycle dependency (Figure 3) . Other previously unpublished cell cycle-dependent 14-3-3 interactions were observed in this screen. For example, TSC2 bound to 14-3-3 more in interphase than in mitosis (Figures 3 and 4B) . Secondly, although there was more PCTAIRE 2 in the interphase and mitotic input samples, higher levels of mitotic PCTAIRE 2 were pulled down with GST-14-3-3. This suggests that the PCTAIRE 2 / 14-3-3 interaction is cell cycle regulated. In contrast, other interactors such as C-TAK1 (Par-1a) bound 14-3-3s equally well in interphase and mitosis. Interestingly, levels of C-TAK1 in mitotic cells were higher than those in interphase cells.
Discussion
In this study, a global proteomics analysis was undertaken to identify proteins that bind to 14-3-3s during interphase and during mitosis. Many different proteins bound to and specifically eluted from 14-3-3 affinity columns. Some of the identified proteins are known 14-3-3 interactors, including Par-1b and histone deacetylase 4. However, several of the identified proteins have not been previously shown to bind 14-3-3s, such as nucleolin (C23), and PCTAIRE 2 and 3. The 14-3-3-binding proteins identified are involved in many different aspects of metabolism, translation, antioxidant and stress responses, cytoskeletal organization, RNA binding, DNA binding and chromatin structure, vesicle trafficking, protein folding, ubiquitination and proteolysis, nucleolar function, nuclear transport, transcription, cell signaling, and cell cycle regulation. In addition, the identified interactors are localized in multiple places in the cell, including the cytosol, nucleus, mitochondrion, and ER. This is consistent with the observation of 14-3-3 proteins throughout the cell (4,44,45). These results illustrate that 14-3-3s are involved in a very wide range of cellular processes throughout interphase and mitosis.
The specificity of 14-3-3 binding to individual proteins identified in this screen remains to be confirmed. Whether each interaction is direct, and whether each varies in a cell cycledependent manner, remains to be examined for many of the identified interactors. However, the fact that several known 14-3-3 targets were identified in this screen suggests that many of the identified proteins are likely to form complexes with 14-3-3s, either directly or indirectly. For instance, sepiapterin reductase is a good candidate 14-3-3 interactor, because two other enzymes in the same biosynthetic pathway, tyrosine and tryptophan hydroxylase, are regulated by 14-3-3 binding (46,47). In addition, the fact that more than half of the identified binding partners were isolated only from mitotic or interphase cells, but not from both, suggests that at least some of 18 these proteins may prove to be either novel regulators of the cell cycle, or to be novel targets of known cell cycle-specific regulatory processes. Perhaps nutrient sensing pathways are regulated in a cell cycle-specific manner: nutrient stimulation of protein translation by mTOR may be more important for the growth phases of the cycle (interphase) than for cell separation during mitosis.
14-3-3 proteins negatively regulate TSC2 which, in turn, negatively regulates mTOR signaling (40-42,48,49). Interestingly, higher levels of 14-3-3 binding to TSC2 were observed during interphase than during mitosis (Figures 3 and 4B) , inferring that TSC2 may be less able to inhibit mTOR during interphase (growth phases) than during mitosis. Peptides were identified by LC-MS/MS analysis. Each protein identification was manually confirmed to ensure that no other human proteins matched the peptide sequences obtained. For proteins with multiple isoforms, an individual isoform is listed only if at least one peptide was 22 observed that is unique to that isoform. Proteins identified by a single peptide are listed only if the sequence was derived from a unique human accession number. For instance, the Wee 1 protein kinase was identified from only one peptide, but its interaction with 14-3-3s has been confirmed in this study and elsewhere (see text). The protein name given in the table is from the database entry where the protein was most functionally informative. In several cases, multiple gi accession numbers match the identified protein; only one is listed. Many peptides corresponding to 14-3-3, keratins (including the 14-3-3 interactors keratin 8 and 18) and several corresponding to GST were obtained; these are not listed. All proteins listed are human proteins.
The number of peptides of each protein that were seen in each sample are listed separated by commas.
It is of note that several proteins that were identified by a large number of peptides are also functionally uncharacterized. Caution must be used in interpreting relative protein abundance from the number of peptides observed, because the two do not necessarily correlate. The identification of a protein in multiple gel bands may indicate protein degradation or smearing on the gel; in some cases the repeated identification of a given protein increases the likelihood that it has been correctly identified as present in the screen.
* represents a known 14-3-3 interactor. Table 2 . Confirmation status of identified 14-3-3 interactors.
GST-14-3-3 pull-downs and GST-14-3-3 Far Western blots were carried out as described for 
